![]() |
市場調査レポート
商品コード
1789214
ホルター心電図の市場規模、シェア、成長分析:デバイス別、用途別、最終用途別、リード数別、地域別 - 産業予測、2025~2032年Holter ECG Market Size, Share, and Growth Analysis, By Device (Single-Channel Holter ECG, Two-Channel Holter ECG), By Application (Cardiac Arrhythmia Monitoring, Ischemia Detection), By End Use, By Lead Count, By Region - Industry Forecast 2025-2032 |
||||||
|
ホルター心電図の市場規模、シェア、成長分析:デバイス別、用途別、最終用途別、リード数別、地域別 - 産業予測、2025~2032年 |
出版日: 2025年08月07日
発行: SkyQuest
ページ情報: 英文 189 Pages
納期: 3~5営業日
|
世界のホルター心電図の市場規模は2023年に12億米ドルと評価され、2024年の13億米ドルから2032年には25億米ドルに成長し、予測期間(2025~2032年)のCAGRは8.6%で成長する見通しです。
ホルター心電図の世界市場は、心血管疾患の有病率の上昇、高齢化、予防ヘルスケアへの関心の高まりなどを背景に成長が見込まれています。ホルター心電図システムに対する需要は、先進国市場、新興国市場ともに堅調ですが、地域によっては機器コストの高騰や償還政策の不備といった課題があります。特にワイヤレス通信、クラウドベースのデータ管理、人工知能などの技術進歩により、デバイスの使いやすさと精度が向上し、ホルター心電図の使用を病院環境以外にも拡大する在宅・遠隔モニタリングソリューションが促進されています。北米は、高度なヘルスケアインフラと疾患に対する意識の高まりに支えられて市場をリードしていますが、アジア太平洋地域は、ヘルスケア施設への投資と心臓関連の問題の発生率の高さに後押しされて、大きな成長の可能性を示しています。
Global Holter ECG Market size was valued at USD 1.2 Billion in 2023, poised to grow from USD 1.3 Billion in 2024 to USD 2.5 Billion by 2032, growing at a CAGR of 8.6% in the forecast period (2025-2032).
The global Holter ECG market is poised for growth driven by the rising prevalence of cardiovascular diseases, an aging population, and an increasing focus on preventive healthcare. Demand for Holter ECG systems is robust in both developed and emerging markets, despite challenges such as high device costs and inadequate reimbursement policies in certain regions. Technological advancements, notably in wireless communication, cloud-based data management, and artificial intelligence, are enhancing device usability and accuracy, facilitating at-home and remote monitoring solutions that extend the use of Holter ECG beyond hospital settings. North America leads the market, supported by sophisticated healthcare infrastructures and heightened disease awareness, while the Asia-Pacific region shows significant growth potential, fueled by investments in healthcare facilities and a higher incidence of heart-related issues.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Holter ECG market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Holter ECG Market Segments Analysis
The global holter ECG market is segmented based on devices, application, end use, lead count, and region. In terms of devices, the market is segmented into single-channel holter ECG, two-channel holter ECG, three-channel holter ECG, and multi-channel holter ECG. Based on applications, the market is segmented into cardiac arrhythmia monitoring, ischemia detection, and electrocardiography (ECG) monitoring. Based on end use, the market is grouped into hospitals, clinics, ambulatory surgery centers, and home healthcare settings. Based on lead count, the market is segmented single-lead holter ECG, two-lead holter ECG, three-lead holter ECG, four-lead holter ECG, and multi-lead holter ECG, Based on Region, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.
Driver of the Global Holter ECG Market
The rise in cardiovascular diseases, including arrhythmias, heart failure, and ischemic heart conditions, is a significant factor driving the growth of the Holter ECG market worldwide. As these health issues become increasingly prevalent, the necessity for continuous and precise cardiac monitoring has intensified. Consequently, there is a growing demand for Holter ECG systems, fueled by an emphasis on early detection and effective long-term management of patients with these conditions. This heightened awareness of cardiovascular health is further propelling innovation and investment in Holter ECG technology, positioning it as an essential tool in modern healthcare for managing heart-related ailments.
Restraints in the Global Holter ECG Market
The Global Holter ECG market faces a significant restraint due to the high costs associated with advanced ECG systems that incorporate sophisticated AI technology and wireless capabilities. These elevated price points pose a barrier to widespread adoption, especially in healthcare systems with constrained budgets, such as those found in low- and middle-income regions. As a result, hospitals and clinics in these areas often opt for more basic and less expensive monitoring solutions rather than the advanced systems, which could enhance patient care. Consequently, the financial burden of these advanced devices restricts their integration into various healthcare settings.
Market Trends of the Global Holter ECG Market
The Global Holter ECG market is experiencing a significant transformation driven by the integration of artificial intelligence into ECG analysis. This technological advancement greatly enhances arrhythmia detection and boosts diagnostic accuracy, allowing for optimal analysis of extensive ECG datasets in a fraction of the time. By reducing clinician workload and supporting more informed clinical decisions, AI-enabled platforms are fostering the development of smarter, more efficient, and automated cardiac monitoring devices. This market trend reflects a broader shift towards automation and sophisticated data analytics in healthcare, ultimately contributing to improved patient outcomes and more effective management of cardiovascular diseases.